0.55 USD
▼-0.03-7.87%
盘后 0.60 +0.30%
2026-08-03
市值
$2.49M
市盈率
—
EPS
-5.86
股息率
—
52 周区间
0.56 – 13.50
成交量
305.99K
Beta
-1.11
目标价
—
52W 低 0.5652W 高 13.50
价格走势
公司简介
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person’s sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cance...